Saverio Minucci

9PUBLICATIONS
146CO-AUTHORS
Solid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 25, 2026
Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.

Elisa Tirtei, Valeria Difilippo, Federico Divincenzo

|Jan 20, 2026
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Nov 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Oct 30, 2025
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Irene Maria Briata, Stefano Spinaci, Parijatham S Thomas

|Dec 19, 2023
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses.

Luca Mazzarella, Fabio Santoro, Roberto Ravasio

|Dec 08, 2021
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response.

Stefania Faletti, Daniela Osti, Elena Ceccacci

Pageof 2

Frequent Collaborators

2 joint publications

Roberto Ravasio

2 joint publications

Luciano Nicosia

2 joint publications

Matteo Ranucci

2 joint publications

Marina Veronesi